Lisanti Capital Growth LLC bought a new stake in shares of Orthopediatrics Corp (NASDAQ:KIDS) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 28,945 shares of the company’s stock, valued at approximately $555,000. Lisanti Capital Growth LLC owned approximately 0.23% of Orthopediatrics at the end of the most recent reporting period.
Separately, Monarch Partners Asset Management LLC purchased a new stake in shares of Orthopediatrics in the fourth quarter worth approximately $339,000. Institutional investors own 1.58% of the company’s stock.
Several brokerages have recently commented on KIDS. BidaskClub downgraded Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Zacks Investment Research downgraded Orthopediatrics from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. BTIG Research reaffirmed a “buy” rating and set a $24.00 price target on shares of Orthopediatrics in a research report on Friday, January 5th. William Blair initiated coverage on Orthopediatrics in a research report on Monday, November 6th. They set an “outperform” rating for the company. Finally, Stifel Nicolaus initiated coverage on Orthopediatrics in a research report on Monday, November 6th. They set a “buy” rating and a $23.00 price target for the company. Two investment analysts have rated the stock with a sell rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $23.67.
Shares of Orthopediatrics Corp (NASDAQ:KIDS) traded down $0.11 during midday trading on Friday, reaching $17.30. The company’s stock had a trading volume of 8,100 shares, compared to its average volume of 25,553. Orthopediatrics Corp has a 1-year low of $15.85 and a 1-year high of $23.00. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00.
TRADEMARK VIOLATION WARNING: This story was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://ledgergazette.com/2018/02/18/lisanti-capital-growth-llc-takes-position-in-orthopediatrics-corp-kids.html.
OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.